INTRACT PHARMA LIMITED

09610219
Active Cambridge

Research and experimental development on biotechnology

9 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
I

INTRACT PHARMA LIMITED

09610219

Research and experimental development on biotechnology

Founded 27 May 2015 Active Cambridge, England 9 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 6 Feb 2026 Next due 28 Feb 2027 8 months remaining
Confirmation Submitted 3 Jun 2026 Next due 10 Jun 2027 11 months remaining
Net assets £1M £992K 2025 year on year
Total assets £1M £1M 2025 year on year
Total Liabilities £196K £159K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

5 High Green Great Shelford Cambridge CB22 5EG England

Website

www.example.com

Full company profile for INTRACT PHARMA LIMITED (09610219), an active life sciences and medical technology company based in Cambridge, England. Incorporated 27 May 2015. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jun → 31 May 2025
Type total-exemption-full
Next accounts 31 May 2026
Due by 28 Feb 2027 8 months remaining

Net Assets, Total Assets & Total Liabilities (2016–2025)

Cash in Bank

£1.35M

Increased by £1.12M (+474%)

Net Assets

£1.29M

Increased by £992.21k (+335%)

Total Liabilities

£196.43k

Increased by £158.66k (+420%)

Turnover

N/A

Employees

9

Increased by 3 (+50%)

Debt Ratio

13%

Increased by 2 (+18%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 May Year End
2024
31 May Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1
Grants 2

Investors (2)

Investor NameInvestor SinceParticipating Rounds
Investor 3Jan 2016Seed
Investor 4Jan 2016Seed

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 2,000 Shares £12k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
4 Aug 20232,000£12k£6

Officers

Officers

1 active 2 resigned
Status
Powell, Keith Adrian, DrDirectorBritishEngland764 Jan 2016Active

Shareholders

Shareholders (4)

Abdul Basit
59.0%
55,800
Cycle Pharmaceuticals Limited
26.5%
25,000

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Vipul Yadiv

Indian

Active
Notified 25 Apr 2022
Residence United Kingdom
DOB August 1988
Nature of Control
  • Significant Influence Or Control

William Pirie Lindsay

Ceased 1 May 2022

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
3 Jun 2026Confirmation StatementConfirmation statement made on 27 May 2026 with no updates
3 Jun 2026OfficersChange to director Dr Keith Powell on 28 May 2026
17 Apr 2026Confirmation StatementReplacement Filing Of Confirmation Statement With Made Up Date
6 Feb 2026AccountsAnnual accounts made up to 31 May 2025
10 Jun 2025Confirmation StatementConfirmation statement made on 27 May 2025 with no updates
3 Jun 2026 Confirmation Statement

Confirmation statement made on 27 May 2026 with no updates

3 Jun 2026 Officers

Change to director Dr Keith Powell on 28 May 2026

17 Apr 2026 Confirmation Statement

Replacement Filing Of Confirmation Statement With Made Up Date

6 Feb 2026 Accounts

Annual accounts made up to 31 May 2025

10 Jun 2025 Confirmation Statement

Confirmation statement made on 27 May 2025 with no updates

Recent Activity

Latest Activity

Confirmation statement made on 27 May 2026 with no updates

3 weeks ago on 3 Jun 2026

Change to director Dr Keith Powell on 28 May 2026

3 weeks ago on 3 Jun 2026

Replacement Filing Of Confirmation Statement With Made Up Date

2 months ago on 17 Apr 2026

Annual accounts made up to 31 May 2025

4 months ago on 6 Feb 2026

Confirmation statement made on 27 May 2025 with no updates

1 years ago on 10 Jun 2025